Annual Cash & Cash Equivalents
$239.57 M
-$142.87 M-37.36%
December 31, 2023
Summary
- As of February 7, 2025, AUTL annual cash & cash equivalents is $239.57 million, with the most recent change of -$142.87 million (-37.36%) on December 31, 2023.
- During the last 3 years, AUTL annual cash & cash equivalents has risen by +$86.27 million (+56.27%).
- AUTL annual cash & cash equivalents is now -37.36% below its all-time high of $382.44 million, reached on December 31, 2022.
Performance
AUTL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$657.07 M
-$48.87 M-6.92%
September 30, 2024
Summary
- As of February 7, 2025, AUTL quarterly cash and cash equivalents is $657.07 million, with the most recent change of -$48.87 million (-6.92%) on September 30, 2024.
- Over the past year, AUTL quarterly cash and cash equivalents has dropped by -$101.46 million (-13.38%).
- AUTL quarterly cash and cash equivalents is now -13.38% below its all-time high of $758.53 million, reached on March 31, 2024.
Performance
AUTL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AUTL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.4% | -13.4% |
| 3 y3 years | +56.3% | +113.7% |
| 5 y5 years | +10.2% | +113.7% |
AUTL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.4% | at low | -13.4% | +303.0% |
| 5 y | 5-year | -37.4% | +56.3% | -13.4% | +328.6% |
| alltime | all time | -37.4% | +753.8% | -13.4% | +444.5% |
Autolus Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $657.07 M(-6.9%) |
| Jun 2024 | - | $705.94 M(-6.9%) |
| Mar 2024 | - | $758.53 M(+216.6%) |
| Dec 2023 | $239.57 M(-37.4%) | $239.57 M(-6.6%) |
| Sep 2023 | - | $256.42 M(-16.6%) |
| Jun 2023 | - | $307.50 M(-10.4%) |
| Mar 2023 | - | $343.03 M(-10.3%) |
| Dec 2022 | $382.44 M(+23.2%) | $382.44 M(+134.5%) |
| Sep 2022 | - | $163.05 M(-24.7%) |
| Jun 2022 | - | $216.44 M(-19.4%) |
| Mar 2022 | - | $268.56 M(-13.5%) |
| Dec 2021 | $310.34 M | $310.34 M(+79.3%) |
| Sep 2021 | - | $173.06 M(-20.0%) |
| Jun 2021 | - | $216.35 M(-9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $239.01 M(+55.9%) |
| Dec 2020 | $153.30 M(-27.2%) | $153.30 M(-13.7%) |
| Sep 2020 | - | $177.69 M(-16.2%) |
| Jun 2020 | - | $212.04 M(-12.9%) |
| Mar 2020 | - | $243.31 M(+15.5%) |
| Dec 2019 | $210.64 M(-3.1%) | $210.64 M(-8.2%) |
| Sep 2019 | - | $229.37 M(-13.8%) |
| Jun 2019 | - | $266.19 M(+41.8%) |
| Mar 2019 | - | $187.73 M(+55.6%) |
| Dec 2018 | $217.45 M(-12.0%) | - |
| Sep 2018 | $246.98 M(+80.2%) | - |
| Mar 2018 | - | $120.67 M |
| Sep 2017 | $137.07 M(+388.5%) | - |
| Sep 2016 | $28.06 M | - |
FAQ
- What is Autolus Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Autolus Therapeutics?
- What is Autolus Therapeutics annual cash & cash equivalents year-on-year change?
- What is Autolus Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Autolus Therapeutics?
- What is Autolus Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Autolus Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of AUTL is $239.57 M
What is the all time high annual cash & cash equivalents for Autolus Therapeutics?
Autolus Therapeutics all-time high annual cash & cash equivalents is $382.44 M
What is Autolus Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, AUTL annual cash & cash equivalents has changed by -$142.87 M (-37.36%)
What is Autolus Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AUTL is $657.07 M
What is the all time high quarterly cash and cash equivalents for Autolus Therapeutics?
Autolus Therapeutics all-time high quarterly cash and cash equivalents is $758.53 M
What is Autolus Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, AUTL quarterly cash and cash equivalents has changed by -$101.46 M (-13.38%)